116 related articles for article (PubMed ID: 25729823)
1. Strontium still authorised despite an unfavourable opinion of the European Pharmacovigilance committee.
Prescrire Int; 2015 Jan; 24(156):15. PubMed ID: 25729823
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.
Donneau AF; Reginster JY
Osteoporos Int; 2014 Feb; 25(2):397-8. PubMed ID: 24322477
[No Abstract] [Full Text] [Related]
3. Strontium ranelate lives to fight another day.
Compston J
Maturitas; 2014 Jun; 78(2):75-6. PubMed ID: 24780410
[No Abstract] [Full Text] [Related]
4. The position of strontium ranelate in today's management of osteoporosis.
Reginster JY; Brandi ML; Cannata-Andía J; Cooper C; Cortet B; Feron JM; Genant H; Palacios S; Ringe JD; Rizzoli R
Osteoporos Int; 2015 Jun; 26(6):1667-71. PubMed ID: 25868510
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
Hiligsmann M; Vanoverberghe M; Neuprez A; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
[TBL] [Abstract][Full Text] [Related]
6. Ten years too long: strontium ranelate, cardiac events, and the European Medicines Agency.
Bolland MJ; Grey A
BMJ; 2016 Sep; 354():i5109. PubMed ID: 27694477
[No Abstract] [Full Text] [Related]
7. Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
Abrahamsen B; Grove EL; Vestergaard P
Osteoporos Int; 2014 Feb; 25(2):757-62. PubMed ID: 24322475
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate for osteoporosis in men. More dangerous than beneficial.
Prescrire Int; 2013 Jun; 22(139):150. PubMed ID: 23866350
[TBL] [Abstract][Full Text] [Related]
9. Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.
Cacoub P; Descamps V; Meyer O; Speirs C; Belissa-Mathiot P; Musette P
Osteoporos Int; 2013 May; 24(5):1751-7. PubMed ID: 23361875
[TBL] [Abstract][Full Text] [Related]
10. Cardiac concerns associated with strontium ranelate.
Reginster JY
Expert Opin Drug Saf; 2014 Sep; 13(9):1209-13. PubMed ID: 25020233
[TBL] [Abstract][Full Text] [Related]
11. Strontium: confusion and hallucinations. Do not use strontium.
Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885972
[No Abstract] [Full Text] [Related]
12. [Adverse drug reactions of strontium ranelate(Protelos(®) in France].
Jonville-Bera AP; Autret-Leca E
Presse Med; 2011 Oct; 40(10):e453-62. PubMed ID: 21885232
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
Rolland Y; Abellan Van Kan G; Gillette-Guyonnet S; Roux C; Boonen S; Vellas B
Bone; 2011 Feb; 48(2):332-8. PubMed ID: 20817053
[TBL] [Abstract][Full Text] [Related]
14. [Osteoporosis in the man: broad indication for strontium ranelate].
MMW Fortschr Med; 2012 Nov; 154(21):86-7. PubMed ID: 23270063
[No Abstract] [Full Text] [Related]
15. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Adami S
Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate-induced DRESS syndrome: first two case reports.
Jonville-Béra AP; Crickx B; Aaron L; Hartingh I; Autret-Leca E
Allergy; 2009 Apr; 64(4):658-9. PubMed ID: 19210353
[No Abstract] [Full Text] [Related]
17. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
Landfeldt E; Lang A; Robbins S; Ström O
Calcif Tissue Int; 2011 Sep; 89(3):234-45. PubMed ID: 21695544
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
Inderjeeth CA; Foo AC; Lai MM; Glendenning P
Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
[TBL] [Abstract][Full Text] [Related]
20. Strontium ranelate: a look back at its use for osteoporosis.
Reginster JY; Neuprez A
Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
